Presidio Medical

About Presidio Medical

Presidio Medical is dedicated to transforming neuromodulation to balance the human nervous system, aiming to end unnecessary pain and improve patients' lives. Their mission focuses on breaking the cycle of constrained thinking about chronic nociceptive pain and creating a world with less suffering by offering relief to patients with limited therapeutic options.

Products & Services

Ultra Low Frequency (ULF™) Neuromodulation System:An innovative therapy blending circuit design, computational modeling, material science, and expertise in neuroscience and electrochemistry. It targets localized pain by reducing neuronal responses, offering long-lasting relief for nociceptive pain patients through a minimally invasive option.

Specialties

Neuromodulation Chronic Pain Therapy Ultra Low Frequency (ULF™) Technology Neuroscience Electrochemistry

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 72000000 MR: - FA: $72 million FAN: 72000000	D: 2023-06-26 FD: 2023-06-26	4 investors

Series C Latest

2023-06-26

$72.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael Onuscheck

Chief Executive Officer and Chairman of the Board

LinkedIn (Pro only)

V

Valerie Cimmarusti

Senior Vice President, Regulatory, Quality & Clinical

LinkedIn (Pro only)

D

Dimas Jiménez

Chief Financial Officer

T

Thomas Nyikos

Vice President of Product Development

A

Andrew Sullivan

Chief Medical Officer

A

Angie Yi

Senior Director of Human Resources

View 14 more team members with Pro

Unlock Full Team Directory

Recent News